ID – 1724
REAL-WORLD SAFETY PROFILE OF TWICE-DAILY DEFERIPRONE FOR IRON OVERLOAD IN US PATIENTS WITH THALASSEMIA, SICKLE CELL DISEASE OR OTHER ANEMIAS
a New York-Presbyterian Hospital-Weill Cornell Medical Center, United States
b UCSF Benioff Children’s Hospital Oakland, United States
c Northwell Health New York, Cohen Children’s Medical Center New York, United States
d Department of Medicine, Division of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, United States
e Chiesi Canada Corp., United States
f Chiesi Brasil, São Paulo, SP, Brazil
g Children’s Hospital Los Angeles, United States
Lido
410
Vezesque se leu este artigo
242
Total PDF
168
Total HTML
Informação do artigo
ISSN: 25311379Idioma original: Inglês
Dados atualizados diariamente
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 1 | 31 | 58 | 89 |
| 2025 12 | 69 | 112 | 181 |
| 2025 11 | 63 | 67 | 130 |
| 2025 10 | 5 | 5 | 10 |
